Q4 2024 Glaukos Corp Earnings Call Transcript

Feb 20, 2025 / 09:30 PM GMT

Release Date Price: €152 (+5.56%)

Transcript 10-K8-K

Key Points

Positve

Glaukos Corp (GKOS) reported record fourth-quarter consolidated net sales of $105.5 million, up 28% year-over-year.
The company achieved full-year 2024 consolidated net sales of $383.5 million, reflecting a 22% growth compared to 2023.
Glaukos Corp (GKOS) introduced a full-year 2025 net sales guidance range of $475 to $485 million.
The company is pioneering new marketplaces within ophthalmology, focusing on novel dropless platforms to improve patient outcomes.
Strong growth in the US glaucoma franchise with record fourth-quarter net sales of $56.3 million, driven by the success of iDose TR.

Negative

The company faces potential headwinds from foreign currency exchange fluctuations and competitive product trials in international markets.
There are ongoing challenges with reimbursement dynamics, particularly in expanding market access for iDose TR.
The expiration of the Hydros royalty is expected to impact non-iDose revenues, potentially leading to flat or low single-digit growth in 2025.
The company anticipates transient turbulence in the market due to new LCD restrictions affecting non-iDose stent growth.
Glaukos Corp (GKOS) is navigating the impact of the Medicaid Drug Rebate Program (MDRP) on its Corneal Health franchise, which may affect growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GKOS.N - Glaukos Corp
Q4 2024 Glaukos Corp Earnings Call
Feb 20, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to Glaco Corporation's first quarter and full year 2020 for financial results conference call. Copies of the company's press release and quarterly summary documents, both issued after the market closed today, are available at www.glocals.com. If you have dialed in and would like to ask a question, please press. AR on your telephone keypad to raise your hand and join the queue. If you would like to withdraw your question, simply press star one again. We ask to please limit yourselves to one question and one follow up. This call is being recorded and an archive replay will be available online in the investor relations section at www.logov.com. I will now turn the call over to Chris Lewis, Vice President of Investor Relations and corporate affairs

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.